Medivir AB (publ) (LON:0GP7)
London flag London · Delayed Price · Currency is GBP · Price in SEK
1.394
+0.508 (57.34%)
Feb 12, 2026, 2:14 PM GMT

Medivir AB Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
432312445118
Market Cap Growth
82.45%85.09%-71.72%-13.83%183.66%-26.18%
Enterprise Value
41179343411
Last Close Price
0.070.200.260.520.640.92
PS Ratio
139.0991.4320.85125.1519.279.86
PB Ratio
8.262.760.732.862.221.42
P/TBV Ratio
8.262.760.732.862.221.42
EV/Sales Ratio
128.9667.6114.4096.2712.695.82
Debt / Equity Ratio
0.100.100.060.080.050.12
Net Debt / Equity Ratio
-0.26-0.44-0.72-0.53-0.74-0.38
Net Debt / EBITDA Ratio
0.220.401.681.153.230.90
Net Debt / FCF Ratio
0.170.412.611.004.250.88
Asset Turnover
0.020.020.030.020.120.08
Quick Ratio
0.461.363.034.375.402.25
Current Ratio
0.461.383.054.395.422.28
Return on Equity (ROE)
-75.11%-73.97%-43.50%-37.46%-29.84%-26.12%
Return on Assets (ROA)
-29.05%-34.76%-22.21%-19.43%-15.27%-15.68%
Return on Invested Capital (ROIC)
-159.90%-203.28%-121.40%-107.49%-79.32%-66.75%
Return on Capital Employed (ROCE)
-108.00%-103.20%-40.50%-43.00%-21.90%-38.80%
Earnings Yield
-14.40%-38.71%-56.14%-16.09%-10.11%-21.15%
FCF Yield
--38.99%-37.50%-18.53%-7.81%-30.14%
Buyback Yield / Dilution
-10.61%-88.71%-8.44%-5.53%-117.45%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.